Viewing Study NCT06678659


Ignite Creation Date: 2025-12-24 @ 2:24 PM
Ignite Modification Date: 2026-01-01 @ 9:35 PM
Study NCT ID: NCT06678659
Status: RECRUITING
Last Update Posted: 2025-12-05
First Post: 2024-10-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
Sponsor: Recursion Pharmaceuticals Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module